135 related articles for article (PubMed ID: 30172651)
1. MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection.
Hong SJ; Feuerstadt P; Brandt LJ
Dig Liver Dis; 2019 Feb; 51(2):275-280. PubMed ID: 30172651
[TBL] [Abstract][Full Text] [Related]
2. Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
Feuerstadt P; Hong SJ; Brandt LJ
Dig Dis Sci; 2020 Feb; 65(2):632-638. PubMed ID: 31440997
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
Bajaj JS; OʼLeary JG; Tandon P; Wong F; Garcia-Tsao G; Kamath PS; Biggins SW; Lai JC; Vargas HE; Maliakkal B; Fallon MB; Thuluvath PJ; Subramanian RM; Thacker LR; Reddy KR
Am J Gastroenterol; 2019 Jul; 114(7):1091-1100. PubMed ID: 31180922
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.
Smith EZ; Northup PG; Argo CK
J Clin Gastroenterol; 2018 Sep; 52(8):747-751. PubMed ID: 28644310
[TBL] [Abstract][Full Text] [Related]
5. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.
Bajaj JS; O'Leary JG; Reddy KR; Wong F; Olson JC; Subramanian RM; Brown G; Noble NA; Thacker LR; Kamath PS;
Hepatology; 2012 Dec; 56(6):2328-35. PubMed ID: 22806618
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Phatharacharukul P; Purpura RD; Gandhi D; Xu H; Bickett-Burkhart K; Chalasani N; Fischer M; Orman ES
Clin Transl Gastroenterol; 2020 Jul; 11(7):e00189. PubMed ID: 32675703
[TBL] [Abstract][Full Text] [Related]
7. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.
Feuerstadt P; Das R; Brandt LJ
Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255
[TBL] [Abstract][Full Text] [Related]
8.
Mantri N; Patel H; Badipatla KR; Sun H; Shaikh D; Gongati S; Nayudu SK
Clin Exp Gastroenterol; 2021; 14():229-235. PubMed ID: 34113145
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Mortality in the Critically Ill Cirrhotic Patient: Is the Model for End-Stage Liver Disease Enough?
Annamalai A; Harada MY; Chen M; Tran T; Ko A; Ley EJ; Nuno M; Klein A; Nissen N; Noureddin M
J Am Coll Surg; 2017 Mar; 224(3):276-282. PubMed ID: 27887981
[TBL] [Abstract][Full Text] [Related]
10. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
[TBL] [Abstract][Full Text] [Related]
11. Copeptin - a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease.
Schneider C; Remmler J; Netto J; Seehofer D; Engelmann C; Berg T; Thiery J; Kaiser T
Clin Chem Lab Med; 2019 Nov; 57(12):1897-1905. PubMed ID: 31199758
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.
Kassam Z; Cribb Fabersunne C; Smith MB; Alm EJ; Kaplan GG; Nguyen GC; Ananthakrishnan AN
Aliment Pharmacol Ther; 2016 Mar; 43(6):725-33. PubMed ID: 26849527
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
[TBL] [Abstract][Full Text] [Related]
14. The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients.
Atamna A; Yahav D; Eliakim-Raz N; Goldberg E; Ben-Zvi H; Barsheshet A; Elis A; Bishara J
Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):779-84. PubMed ID: 26864041
[TBL] [Abstract][Full Text] [Related]
15. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
Hu XP; Gao J
World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for short- and long-term mortality in very old patients with Clostridium difficile infection: A retrospective study.
Leibovici-Weissman Y; Atamna A; Schlesinger A; Eliakim-Raz N; Bishara J; Yahav D
Geriatr Gerontol Int; 2017 Oct; 17(10):1378-1383. PubMed ID: 27647625
[TBL] [Abstract][Full Text] [Related]
17. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
18. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
Mamic P; Heidenreich PA; Hedlin H; Tennakoon L; Staudenmayer KL
J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
[TBL] [Abstract][Full Text] [Related]
19. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S
Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
